Barry S. Zingman

11.2k total citations · 1 hit paper
57 papers, 1.6k citations indexed

About

Barry S. Zingman is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Barry S. Zingman has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 27 papers in Epidemiology and 20 papers in Virology. Recurrent topics in Barry S. Zingman's work include HIV/AIDS Research and Interventions (27 papers), HIV Research and Treatment (18 papers) and HIV/AIDS drug development and treatment (18 papers). Barry S. Zingman is often cited by papers focused on HIV/AIDS Research and Interventions (27 papers), HIV Research and Treatment (18 papers) and HIV/AIDS drug development and treatment (18 papers). Barry S. Zingman collaborates with scholars based in United States, United Kingdom and Germany. Barry S. Zingman's co-authors include Judith A. Aberg, Michael A. Horberg, Joel E. Gallant, Khalil G. Ghanem, Patricia Emmanuel, Jonathan Shuter, Richard A. Rode, Uriel R. Felsen, F. Meunier and Stuart M. Levitz and has published in prestigious journals such as Blood, Clinical Infectious Diseases and American Journal of Public Health.

In The Last Decade

Barry S. Zingman

54 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America

2013 363 citations Barry S. Zingman et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry S. Zingman United States	20	985	652	438	345	186	57	1.6k
Patricia Emmanuel United States	23	1.0k 1.1×	792 1.2×	360 0.8×	504 1.5×	240 1.3×	54	2.1k
Lorie Benning United States	22	936 1.0×	579 0.9×	493 1.1×	858 2.5×	146 0.8×	44	1.9k
Julio Collazos Spain	21	727 0.7×	423 0.6×	269 0.6×	318 0.9×	167 0.9×	79	1.5k
Antonio Ocampo Spain	22	1.0k 1.1×	704 1.1×	587 1.3×	223 0.6×	108 0.6×	86	1.8k
Vania Giacomet Italy	24	963 1.0×	436 0.7×	484 1.1×	630 1.8×	126 0.7×	107	1.7k
James Hakim Zimbabwe	23	1.2k 1.2×	956 1.5×	370 0.8×	375 1.1×	177 1.0×	89	2.0k
Sandra Wagner Cardoso Brazil	23	1.0k 1.0×	575 0.9×	435 1.0×	769 2.2×	75 0.4×	117	1.9k
Trevor A. Crowell United States	22	945 1.0×	565 0.9×	396 0.9×	203 0.6×	170 0.9×	121	1.6k
Ana Guelar Spain	24	1.2k 1.2×	639 1.0×	542 1.2×	789 2.3×	316 1.7×	48	2.0k
Alejandro Dorenbaum United States	21	646 0.7×	342 0.5×	246 0.6×	154 0.4×	300 1.6×	40	1.7k

Countries citing papers authored by Barry S. Zingman

Since Specialization

Citations

This map shows the geographic impact of Barry S. Zingman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry S. Zingman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry S. Zingman more than expected).

Fields of papers citing papers by Barry S. Zingman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry S. Zingman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry S. Zingman. The network helps show where Barry S. Zingman may publish in the future.

Co-authorship network of co-authors of Barry S. Zingman

This figure shows the co-authorship network connecting the top 25 collaborators of Barry S. Zingman. A scholar is included among the top collaborators of Barry S. Zingman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry S. Zingman. Barry S. Zingman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knox, Justin, Efrat Aharonovich, Barry S. Zingman, et al.. (2024). HealthCall: Smartphone Enhancement of Brief Interventions to Improve HIV Medication Adherence Among Patients in HIV Care. AIDS and Behavior. 28(6). 1912–1922.

Hasin, Deborah S., Efrat Aharonovich, Barry S. Zingman, et al.. (2022). HealthCall: A randomized trial assessing a smartphone enhancement of brief interventions to reduce heavy drinking in HIV care. Journal of Substance Abuse Treatment. 138. 108733–108733. 9 indexed citations

Taylor, Tonya, et al.. (2019). Pathways to HIV Pre-exposure Prophylaxis Among Women Prescribed PrEP at an Urban Sexual Health Clinic. Journal of the Association of Nurses in AIDS Care. 30(3). 321–329. 35 indexed citations

Yin, Michael T., Arindam RoyChoudhury, Kyle K. Nishiyama, et al.. (2018). Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women. Osteoporosis International. 29(4). 871–879. 5 indexed citations

Hanna, David B., Uriel R. Felsen, Mindy Ginsberg, et al.. (2016). Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies. AIDS Research and Human Retroviruses. 32(10-11). 955–963. 25 indexed citations

Luque, Amneris E., Barry S. Zingman, Margaret A. Fischl, et al.. (2016). Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. Current Vascular Pharmacology. 14(3). 280–287. 8 indexed citations

Tsukrov, Dina, Alfred Morgenstern, Frank Bruchertseifer, et al.. (2016). Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals. Frontiers in Medicine. 3. 41–41. 7 indexed citations

Krachmarov, Chavdar, Zhong Lai, William Honnen, et al.. (2013). Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking. Virology. 448. 363–374. 9 indexed citations

Mahoney, Jeannette R., et al.. (2013). Cognitive Reserve Protects Against Apathy in Individuals with Human Immunodeficiency Virus. Archives of Clinical Neuropsychology. 29(1). 110–120. 20 indexed citations

10.

Ma, Qing, Barry S. Zingman, Amneris E. Luque, et al.. (2011). Therapeutic Drug Monitoring of Protease Inhibitors and Efavirenz in HIV-Infected Individuals With Active Substance-Related Disorders. Therapeutic Drug Monitoring. 33(3). 309–314. 3 indexed citations

11.

Suleiman, Jamal, Barry S. Zingman, Ricardo Sobhie Diaz, et al.. (2010). Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment‐Experienced Subjects: 48‐Week Results of the VICTOR‐E1 Phase 2 Trial. The Journal of Infectious Diseases. 201(4). 590–599. 37 indexed citations

12.

Shuter, Jonathan, et al.. (2009). Occurrence of Selective Ritonavir Nonadherence and Dose-Staggering in Recipients of Boosted HIV-1 Protease Inhibitor Therapy. HIV Clinical Trials. 10(3). 135–142. 3 indexed citations

13.

Ma, Qing, Barry S. Zingman, Richard C. Reichman, et al.. (2007). Assessing the Impact of Substance use and Hepatitis Coinfection on Atazanavir and Lopinavir Trough Concentrations in HIV-Infected Patients During Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 29(5). 560–565. 13 indexed citations

14.

DiFrancesco, Robin, Margaret A. Fischl, Barry S. Zingman, et al.. (2007). Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users. Journal of Pharmaceutical and Biomedical Analysis. 44(1). 188–195. 4 indexed citations

15.

DiFrancesco, Robin, Barry S. Zingman, Richard C. Reichman, et al.. (2007). Integration of Atazanavir into an Existing Liquid Chromatography UV Method for Protease Inhibitors: Validation and Application. Therapeutic Drug Monitoring. 29(1). 103–109. 19 indexed citations

16.

Frater, Robert W.M., et al.. (2003). Cardiac Surgery in the Patient with Human Immunodeficiency Virus. Advances in cardiology. 40. 219–225. 3 indexed citations

17.

Fichtenbaum, Carl J., Robert Zackin, Natasa Rajicic, et al.. (2000). Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. AIDS. 14(7). 845–852. 19 indexed citations

18.

Zingman, Barry S.. (1996). Treatment of mucosal candidiasis in HIV-infected patients. Journal de Mycologie Médicale. 6. 3–11. 8 indexed citations

19.

Beenhouwer, David O., Joshua D. Nosanchuk, & Barry S. Zingman. (1996). Recurrent meningitis in a 38-year-old man with cirrhosis. International Journal of Infectious Diseases. 1(2). 98–101. 1 indexed citations

20.

Zingman, Barry S., et al.. (1992). Invasive Infections Due to Candida krusei: Report of Ten Cases of Fungemia that Include Three Cases of Endophthalmitis. Clinical Infectious Diseases. 14(2). 472–478. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact